These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. The therapeutic applications of antimicrobial peptides (AMPs): a patent review. Kang HK; Kim C; Seo CH; Park Y J Microbiol; 2017 Jan; 55(1):1-12. PubMed ID: 28035594 [TBL] [Abstract][Full Text] [Related]
12. The LL-37 domain: A clue to cathelicidin immunomodulatory response? Leite ML; Duque HM; Rodrigues GR; da Cunha NB; Franco OL Peptides; 2023 Jul; 165():171011. PubMed ID: 37068711 [TBL] [Abstract][Full Text] [Related]
13. Cathelicidins--a family of multifunctional antimicrobial peptides. Bals R; Wilson JM Cell Mol Life Sci; 2003 Apr; 60(4):711-20. PubMed ID: 12785718 [TBL] [Abstract][Full Text] [Related]
14. The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Nijnik A; Hancock RE Curr Opin Hematol; 2009 Jan; 16(1):41-7. PubMed ID: 19068548 [TBL] [Abstract][Full Text] [Related]
15. Tissue-specific Regulation of Innate Immune Responses by Human Cathelicidin LL-37. Chieosilapatham P; Ikeda S; Ogawa H; Niyonsaba F Curr Pharm Des; 2018; 24(10):1079-1091. PubMed ID: 29589544 [TBL] [Abstract][Full Text] [Related]
16. Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide. Mookherjee N; Wilson HL; Doria S; Popowych Y; Falsafi R; Yu JJ; Li Y; Veatch S; Roche FM; Brown KL; Brinkman FS; Hokamp K; Potter A; Babiuk LA; Griebel PJ; Hancock RE J Leukoc Biol; 2006 Dec; 80(6):1563-74. PubMed ID: 16943385 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial peptide LL-37 and IDR-1 ameliorate MRSA pneumonia in vivo. Hou M; Zhang N; Yang J; Meng X; Yang R; Li J; Sun T Cell Physiol Biochem; 2013; 32(3):614-23. PubMed ID: 24021961 [TBL] [Abstract][Full Text] [Related]
18. Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. Dean SN; Bishop BM; van Hoek ML BMC Microbiol; 2011 May; 11():114. PubMed ID: 21605457 [TBL] [Abstract][Full Text] [Related]
19. Unique features of human cathelicidin LL-37. Bandurska K; Berdowska A; BarczyĆska-Felusiak R; Krupa P Biofactors; 2015; 41(5):289-300. PubMed ID: 26434733 [TBL] [Abstract][Full Text] [Related]
20. Cathelicidin Antimicrobial Peptides with Reduced Activation of Toll-Like Receptor Signaling Have Potent Bactericidal Activity against Colistin-Resistant Bacteria. Kao C; Lin X; Yi G; Zhang Y; Rowe-Magnus DA; Bush K mBio; 2016 Sep; 7(5):. PubMed ID: 27651360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]